Aspirin resistance: Fact or fiction? A point of view. - Wikidata - wikimedia - TriplyDB

Aspirin resistance: Fact or fiction? A point of view.

Aspirin resistance: Fact or fiction? A point of view.

http://www.wikidata.org/entity/Q34389630

about

Personalized vascular medicine: individualizing drug therapy Evaluation of platelet function using PFA-100® in patients treated with Acetylsalicylic acid and qualified for Trauma and Orthopedic surgery procedures.Platelet function testing in contemporary clinical and interventional practice.

P2860

Q37142852-8A514DFD-39D7-4619-B319-20F76ACAAD96 Q39839175-D9949BDF-2C79-4D86-A007-63DE4DACFA0A Q51746988-28ECC1AD-36FE-441C-83AF-EF3B67682DB0

P2860

Aspirin resistance: Fact or fiction? A point of view.

http://www.wikidata.org/entity/Q34389630

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aspirin resistance: Fact or fiction? A point of view.

@ast

Aspirin resistance: Fact or fiction? A point of view.

@en

Aspirin resistance: Fact or fiction? A point of view.

@nl

type

label

Aspirin resistance: Fact or fiction? A point of view.

@ast

Aspirin resistance: Fact or fiction? A point of view.

@en

Aspirin resistance: Fact or fiction? A point of view.

@nl

prefLabel

Aspirin resistance: Fact or fiction? A point of view.

@ast

Aspirin resistance: Fact or fiction? A point of view.

@en

Aspirin resistance: Fact or fiction? A point of view.

@nl

P1433

Q34389630-31B5AE25-A599-4008-97F0-E423B06953E3

P1476

Q34389630-4541529C-B525-4C61-8E1A-537358F0FBF3

P2093

Q34389630-34357151-0B0E-4004-96E7-78A7E8B442C2

Q34389630-56EA7F04-8692-40AB-A560-481566AFD3D3

P2860

Q34389630-00E0E8D8-DE2B-415C-ADDA-BE27738F0883

Q34389630-0214A55D-5471-438A-A749-149C96B5DCB8

Q34389630-047385E2-BA6B-4184-B469-E228DEFD41B4

Q34389630-06F233E6-C1AF-47A4-A9FD-00381EE4F3BA

Q34389630-0704CFD1-3582-410E-86DE-2CECF2FE5BA6

Q34389630-14270D09-724E-48A3-A7A3-E5C9D5D4B815

Q34389630-18BF1FB9-F9CC-4700-902D-BBDF96D18D8B

Q34389630-1AA4AFEC-71C0-49DC-8D83-EAA4ED26C61D

Q34389630-1AC0020D-963A-495E-BA19-55A0C5CA9313

Q34389630-1B817B5B-2220-4C3E-9C64-9C8FA324DD89

P304

Q34389630-45C45F55-6535-489A-8F84-55E1B1274A3E

P31

Q34389630-729F1545-2A7D-4D9E-9615-D148CF58B10E

Q34389630-9323e24f-9267-4438-a000-ae9608091b1d

P356

Q34389630-3DFA6271-376A-4E61-9978-95113E0E7CD3

P433

Q34389630-4B506A8E-5ECF-4E69-B490-273D0E0AE59E

P478

Q34389630-6ED0C6D0-07BD-4820-8DC6-B49AAD98E703

P577

Q34389630-C3387FC1-0D85-43BF-B512-35BB0998F5CD

P5875

Q34389630-9800CDA5-A016-4AD1-9368-11F405192B59

P698

Q34389630-681A52A4-93C0-42F7-BA09-D5C5A85131BA

P921

Q34389630-0B4C3BE4-6844-4C77-8EE6-A9D648721FD0

P932

Q34389630-F7F9B06E-D94C-4057-8165-2ACCCF3211E5

P356

P1433

World journal of cardiology

P1476

Aspirin resistance: Fact or fiction? A point of view.

@en

P2093

Bhavna Mohandas

http://www.w3.org/2001/XMLSchema#string

Jawahar L Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

The discovery of aspirin: a reappraisal

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

Antiplatelet effect of aspirin in patients with cerebrovascular disease

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy

Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer

P304

280-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4330/WJC.V2.I9.280

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49685643

http://www.w3.org/2001/XMLSchema#string

P698

21160604

http://www.w3.org/2001/XMLSchema#string

P921

P932

2998828

http://www.w3.org/2001/XMLSchema#string